Modeling considerations for in vivo quantification of the dopamine transporter using [11C]PE2I and positron emission tomography (original) (raw)
Quantitative analysis of dopamine transporters in human brain using [11C]PE2I and positron emission tomography: evaluation of reference tissue models
Iwao Kanno
Annals of Nuclear Medicine, 2010
View PDFchevron_right
Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: quantitative modeling and test–retest reproducibility
Lars Farde
Journal of Cerebral Blood Flow & Metabolism, 2008
View PDFchevron_right
[ 11 C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain
Denis Guilloteau
European Journal of Nuclear Medicine and Molecular Imaging, 2003
View PDFchevron_right
Simplified estimation of binding parameters based on image-derived reference tissue models for dopamine transporter bindings in non-human primates using [ 18 F]FE-PE2I and PET
K. Sakaguchi
2017
View PDFchevron_right
PE2I: A Radiopharmaceutical for In vivo Exploration of the Dopamine Transporter
Sylvie Chalon
CNS Drug Reviews, 2008
View PDFchevron_right
Pharmacokinetics and dosimetry of iodine-123 labelled PE2I in humans, a radioligand for dopamine transporter imaging
Sylvie Chalon
European Journal of Nuclear Medicine and Molecular Imaging, 1998
View PDFchevron_right
Quantification of dopamine transporter binding using [18F]FP-β-CIT and positron emission tomography
Bart Van Berckel
Journal of Cerebral Blood Flow & Metabolism, 2007
View PDFchevron_right
Kinetic Analysis and Quantification of the Dopamine Transporter in the Nonhuman Primate Brain with 11C-PE2I and 18F-FE-PE2I
Denis Guilloteau
Journal of Nuclear Medicine, 2010
View PDFchevron_right
Assessment of 11C-PE2I Binding to the Neuronal Dopamine Transporter in Humans with the High-Spatial-Resolution PET Scanner HRRT
Claire Leroy
Journal of Nuclear Medicine, 2007
View PDFchevron_right
Iodine-123 labelled PE2I for dopamine transporter imaging: influence of age in healthy subjects
Jari Tiihonen
European Journal of Nuclear Medicine and Molecular Imaging, 1999
View PDFchevron_right
Pharmacokinetic evaluation of [18F]PR04.MZ for PET/CT imaging and quantification of dopamine transporters in the human brain
Jonathan Flores
European Journal of Nuclear Medicine and Molecular Imaging, 2019
View PDFchevron_right
Reproducibility of [123I]PE2I binding to dopamine transporters with SPECT
Gitte Knudsen
European Journal of Nuclear Medicine and Molecular Imaging, 2007
View PDFchevron_right
Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [11C]PE2I
Jong-In Hong
European Journal of Nuclear Medicine and Molecular Imaging, 2007
View PDFchevron_right
Whole-Body Biodistribution and Dosimetry of the Dopamine Transporter Radioligand 18F-FE-PE2I in Human Subjects
Jan Axelsson
The Journal of Nuclear Medicine, 2018
View PDFchevron_right
{"__content__"=>"Whole-body biodistribution and dosimetry of the dopamine transporter radioligand F-FE-PE2I in human subjects.", "sup"=>{"__content__"=>"18"}}
Jan Axelsson
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018
View PDFchevron_right
Synthesis, radiolabeling and preliminary in vivo evaluation of [18F]FE-PE2I, a new probe for the dopamine transporter
Denis Guilloteau
Bioorganic & Medicinal Chemistry Letters, 2009
View PDFchevron_right
Quantification of dopamine transporter binding using [18F]FP-�-CIT and positron emission tomography
Bart Van Berckel
J Cerebr Blood Flow Metabol, 2007
View PDFchevron_right
Visualization of the Dopamine Transporter in the Human Brain Postmortem with the New Selective Ligand [125I]PE2I
Sylvie Chalon
NeuroImage, 1999
View PDFchevron_right
Visualization of the Dopamine Transporter in the Human Brain Postmortem with the New Selective Ligand [125I] PE2I* 1
Denis Guilloteau
Neuroimage, 1999
View PDFchevron_right
In vivo PET quantification of the dopamine transporter in rat brain with [18F]LBT-999
Denis Guilloteau
Nuclear Medicine and Biology, 2014
View PDFchevron_right
Quantification of [123I]PE2I binding to dopamine transporters with SPET
Steven Haugbøl
European Journal of Nuclear Medicine and Molecular Imaging, 2002
View PDFchevron_right